首页> 外文期刊>JAMA: the Journal of the American Medical Association >Acute renal failure in critically ill patients: a multinational, multicenter study.
【24h】

Acute renal failure in critically ill patients: a multinational, multicenter study.

机译:重症患者的急性肾功能衰竭:一项多国,多中心研究。

获取原文
获取原文并翻译 | 示例
           

摘要

CONTEXT: Although acute renal failure (ARF) is believed to be common in the setting of critical illness and is associated with a high risk of death, little is known about its epidemiology and outcome or how these vary in different regions of the world. OBJECTIVES: To determine the period prevalence of ARF in intensive care unit (ICU) patients in multiple countries; to characterize differences in etiology, illness severity, and clinical practice; and to determine the impact of these differences on patient outcomes. DESIGN, SETTING, AND PATIENTS: Prospective observational study of ICU patients who either were treated with renal replacement therapy (RRT) or fulfilled at least 1 of the predefined criteria for ARF from September 2000 to December 2001 at 54 hospitals in 23 countries. MAIN OUTCOME MEASURES: Occurrence of ARF, factors contributing to etiology, illness severity, treatment, need for renal support after hospital discharge, and hospital mortality. RESULTS: Of 29 269 critically ill patients admitted during the study period, 1738 (5.7%; 95% confidence interval [CI], 5.5%-6.0%) had ARF during their ICU stay, including 1260 who were treated with RRT. The most common contributing factor to ARF was septic shock (47.5%; 95% CI, 45.2%-49.5%). Approximately 30% of patients had preadmission renal dysfunction. Overall hospital mortality was 60.3% (95% CI, 58.0%-62.6%). Dialysis dependence at hospital discharge was 13.8% (95% CI, 11.2%-16.3%) for survivors. Independent risk factors for hospital mortality included use of vasopressors (odds ratio [OR], 1.95; 95% CI, 1.50-2.55; P<.001), mechanical ventilation (OR, 2.11; 95% CI, 1.58-2.82; P<.001), septic shock (OR, 1.36; 95% CI, 1.03-1.79; P = .03), cardiogenic shock (OR, 1.41; 95% CI, 1.05-1.90; P = .02), and hepatorenal syndrome (OR, 1.87; 95% CI, 1.07-3.28; P = .03). CONCLUSION: In this multinational study, the period prevalence of ARF requiring RRT in the ICU was between 5% and 6% and was associated with a high hospital mortality rate.
机译:背景:尽管人们认为急性肾衰竭(ARF)在重症疾病中很常见,并且与高死亡风险相关,但对其流行病学和预后以及在世界各地的变化知之甚少。目的:确定多个国家重症监护病房(ICU)患者的ARF患病率;表征病因,疾病严重程度和临床实践方面的差异;并确定这些差异对患者预后的影响。设计,地点和患者:2000年9月至2001年12月在23个国家的54所医院接受肾替代疗法(RRT)治疗或至少达到ARF预定标准之一的ICU患者的前瞻性观察性研究。主要观察指标:ARF的发生,病因,病情轻重,治疗,出院后需要肾脏支持以及医院死亡率等因素。结果:在研究期间入院的29269名危重病人中,有1738名(5.7%; 95%置信区间[CI],5.5%-6.0%)在ICU住院期间患有ARF,包括1260名接受RRT治疗的患者。引起ARF的最常见因素是败血性休克(47.5%; 95%CI,45.2%-49.5%)。约30%的患者患有入院前肾功能不全。总体医院死亡率为60.3%(95%CI,58.0%-62.6%)。幸存者在出院时的透析依赖性为13.8%(95%CI,11.2%-16.3%)。医院死亡率的独立危险因素包括使用血管加压药(比值比[OR],1.95; 95%CI,1.50-2.55; P <.001),机械通气(OR,2.11; 95%CI,1.58-2.82; P < .001),败血性休克(OR,1.36; 95%CI,1.03-1.79; P = .03),心源性休克(OR,1.41; 95%CI,1.05-1.90; P = .02)和肝肾综合征( OR,1.87; 95%CI,1.07-3.28; P = .03)。结论:在这项跨国研究中,ICU中需要RRT的ARF患病率在5%至6%之间,并且与高医院死亡率相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号